 | • レポートコード：MRC2Q12-16718 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、アルツハイマー病治療薬の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアルツハイマー病治療薬のグローバル市場のxxx％を占める「コリンエステラーゼ阻害剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「オンライン販売」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 アルツハイマー病治療薬の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのアルツハイマー病治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 アルツハイマー病治療薬のグローバル主要プレイヤーには、Eisai Co., Ltd.、Novartis AG、Abbvie inc. (Allergan Plc)、Adamas Pharmaceuticals, Inc.、H. Lundbeck A/S、Biogen、AC Immune、DAIICHI SANKYO COMPANY, LIMITED、Johnson & Johnson Services Inc、TauRx Pharmaceuticals Ltd、F. Hoffmann La Roche Ltd.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 アルツハイマー病治療薬市場は、種類と用途によって区分されます。世界のアルツハイマー病治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 コリンエステラーゼ阻害剤、N-メチル-D-アスパラギン酸（NMDA）受容体拮抗剤、配合剤、その他 【用途別セグメント】 オンライン販売、オフライン販売 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - アルツハイマー病治療薬製品概要 - 種類別市場（コリンエステラーゼ阻害剤、N-メチル-D-アスパラギン酸（NMDA）受容体拮抗剤、配合剤、その他） - 用途別市場（オンライン販売、オフライン販売） - 調査の目的 ・エグゼクティブサマリー - 世界のアルツハイマー病治療薬販売量予測2017-2028 - 世界のアルツハイマー病治療薬売上予測2017-2028 - アルツハイマー病治療薬の地域別販売量 - アルツハイマー病治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別アルツハイマー病治療薬販売量 - 主要メーカー別アルツハイマー病治療薬売上 - 主要メーカー別アルツハイマー病治療薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（コリンエステラーゼ阻害剤、N-メチル-D-アスパラギン酸（NMDA）受容体拮抗剤、配合剤、その他） - アルツハイマー病治療薬の種類別販売量 - アルツハイマー病治療薬の種類別売上 - アルツハイマー病治療薬の種類別価格 ・用途別市場規模（オンライン販売、オフライン販売） - アルツハイマー病治療薬の用途別販売量 - アルツハイマー病治療薬の用途別売上 - アルツハイマー病治療薬の用途別価格 ・北米市場 - 北米のアルツハイマー病治療薬市場規模（種類別、用途別） - 主要国別のアルツハイマー病治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのアルツハイマー病治療薬市場規模（種類別、用途別） - 主要国別のアルツハイマー病治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のアルツハイマー病治療薬市場規模（種類別、用途別） - 主要国別のアルツハイマー病治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のアルツハイマー病治療薬市場規模（種類別、用途別） - 主要国別のアルツハイマー病治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのアルツハイマー病治療薬市場規模（種類別、用途別） - 主要国別のアルツハイマー病治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Eisai Co., Ltd.、Novartis AG、Abbvie inc. (Allergan Plc)、Adamas Pharmaceuticals, Inc.、H. Lundbeck A/S、Biogen、AC Immune、DAIICHI SANKYO COMPANY, LIMITED、Johnson & Johnson Services Inc、TauRx Pharmaceuticals Ltd、F. Hoffmann La Roche Ltd. ・産業チェーン及び販売チャネル分析 - アルツハイマー病治療薬の産業チェーン分析 - アルツハイマー病治療薬の原材料 - アルツハイマー病治療薬の生産プロセス - アルツハイマー病治療薬の販売及びマーケティング - アルツハイマー病治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - アルツハイマー病治療薬の産業動向 - アルツハイマー病治療薬のマーケットドライバー - アルツハイマー病治療薬の課題 - アルツハイマー病治療薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Alzheimer’s Treatment Drugs estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Alzheimer’s Treatment Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Alzheimer’s Treatment Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Alzheimer’s Treatment Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Alzheimer’s Treatment Drugs include Eisai Co., Ltd., Novartis AG, Abbvie inc. (Allergan Plc), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, DAIICHI SANKYO COMPANY, LIMITED and Johnson & Johnson Services Inc, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Alzheimer’s Treatment Drugs companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Alzheimer’s Treatment Drugs market. Further, it explains the major drivers and regional dynamics of the global Alzheimer’s Treatment Drugs market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Eisai Co., Ltd.
Novartis AG
Abbvie inc. (Allergan Plc)
Adamas Pharmaceuticals, Inc.
H. Lundbeck A/S
Biogen
AC Immune
DAIICHI SANKYO COMPANY, LIMITED
Johnson & Johnson Services Inc
TauRx Pharmaceuticals Ltd
F. Hoffmann La Roche Ltd.
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Alzheimer’s Treatment Drugs Segment by Type
Cholinesterase Inhibitors
N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
Combination Drug
Others
Alzheimer’s Treatment Drugs Segment by Application
Online Sales
Offline Sales
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Alzheimer’s Treatment Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Alzheimer’s Treatment Drugs market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Alzheimer’s Treatment Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Alzheimer’s Treatment Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Alzheimer’s Treatment Drugs revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Alzheimer’s Treatment Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Alzheimer’s Treatment Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eisai Co., Ltd., Novartis AG, Abbvie inc. (Allergan Plc), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, DAIICHI SANKYO COMPANY, LIMITED and Johnson & Johnson Services Inc, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Alzheimer’s Treatment Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer’s Treatment Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alzheimer’s Treatment Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer’s Treatment Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cholinesterase Inhibitors
1.2.3 N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
1.2.4 Combination Drug
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alzheimer’s Treatment Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer’s Treatment Drugs Market Perspective (2017-2028)
2.2 Alzheimer’s Treatment Drugs Growth Trends by Region
2.2.1 Alzheimer’s Treatment Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Alzheimer’s Treatment Drugs Historic Market Size by Region (2017-2022)
2.2.3 Alzheimer’s Treatment Drugs Forecasted Market Size by Region (2023-2028)
2.3 Alzheimer’s Treatment Drugs Market Dynamics
2.3.1 Alzheimer’s Treatment Drugs Industry Trends
2.3.2 Alzheimer’s Treatment Drugs Market Drivers
2.3.3 Alzheimer’s Treatment Drugs Market Challenges
2.3.4 Alzheimer’s Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer’s Treatment Drugs Players by Revenue
3.1.1 Global Top Alzheimer’s Treatment Drugs Players by Revenue (2017-2022)
3.1.2 Global Alzheimer’s Treatment Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Alzheimer’s Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alzheimer’s Treatment Drugs Revenue
3.4 Global Alzheimer’s Treatment Drugs Market Concentration Ratio
3.4.1 Global Alzheimer’s Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer’s Treatment Drugs Revenue in 2021
3.5 Alzheimer’s Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Alzheimer’s Treatment Drugs Product Solution and Service
3.7 Date of Enter into Alzheimer’s Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer’s Treatment Drugs Breakdown Data by Type
4.1 Global Alzheimer’s Treatment Drugs Historic Market Size by Type (2017-2022)
4.2 Global Alzheimer’s Treatment Drugs Forecasted Market Size by Type (2023-2028)
5 Alzheimer’s Treatment Drugs Breakdown Data by Application
5.1 Global Alzheimer’s Treatment Drugs Historic Market Size by Application (2017-2022)
5.2 Global Alzheimer’s Treatment Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Alzheimer’s Treatment Drugs Market Size (2017-2028)
6.2 North America Alzheimer’s Treatment Drugs Market Size by Type
6.2.1 North America Alzheimer’s Treatment Drugs Market Size by Type (2017-2022)
6.2.2 North America Alzheimer’s Treatment Drugs Market Size by Type (2023-2028)
6.2.3 North America Alzheimer’s Treatment Drugs Market Share by Type (2017-2028)
6.3 North America Alzheimer’s Treatment Drugs Market Size by Application
6.3.1 North America Alzheimer’s Treatment Drugs Market Size by Application (2017-2022)
6.3.2 North America Alzheimer’s Treatment Drugs Market Size by Application (2023-2028)
6.3.3 North America Alzheimer’s Treatment Drugs Market Share by Application (2017-2028)
6.4 North America Alzheimer’s Treatment Drugs Market Size by Country
6.4.1 North America Alzheimer’s Treatment Drugs Market Size by Country (2017-2022)
6.4.2 North America Alzheimer’s Treatment Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Alzheimer’s Treatment Drugs Market Size (2017-2028)
7.2 Europe Alzheimer’s Treatment Drugs Market Size by Type
7.2.1 Europe Alzheimer’s Treatment Drugs Market Size by Type (2017-2022)
7.2.2 Europe Alzheimer’s Treatment Drugs Market Size by Type (2023-2028)
7.2.3 Europe Alzheimer’s Treatment Drugs Market Share by Type (2017-2028)
7.3 Europe Alzheimer’s Treatment Drugs Market Size by Application
7.3.1 Europe Alzheimer’s Treatment Drugs Market Size by Application (2017-2022)
7.3.2 Europe Alzheimer’s Treatment Drugs Market Size by Application (2023-2028)
7.3.3 Europe Alzheimer’s Treatment Drugs Market Share by Application (2017-2028)
7.4 Europe Alzheimer’s Treatment Drugs Market Size by Country
7.4.1 Europe Alzheimer’s Treatment Drugs Market Size by Country (2017-2022)
7.4.2 Europe Alzheimer’s Treatment Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer’s Treatment Drugs Market Size (2017-2028)
8.2 Asia-Pacific Alzheimer’s Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Alzheimer’s Treatment Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Alzheimer’s Treatment Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Alzheimer’s Treatment Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Alzheimer’s Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Alzheimer’s Treatment Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Alzheimer’s Treatment Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Alzheimer’s Treatment Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Alzheimer’s Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Alzheimer’s Treatment Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Alzheimer’s Treatment Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Alzheimer’s Treatment Drugs Market Size (2017-2028)
9.2 Latin America Alzheimer’s Treatment Drugs Market Size by Type
9.2.1 Latin America Alzheimer’s Treatment Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Alzheimer’s Treatment Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Alzheimer’s Treatment Drugs Market Share by Type (2017-2028)
9.3 Latin America Alzheimer’s Treatment Drugs Market Size by Application
9.3.1 Latin America Alzheimer’s Treatment Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Alzheimer’s Treatment Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Alzheimer’s Treatment Drugs Market Share by Application (2017-2028)
9.4 Latin America Alzheimer’s Treatment Drugs Market Size by Country
9.4.1 Latin America Alzheimer’s Treatment Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Alzheimer’s Treatment Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer’s Treatment Drugs Market Size (2017-2028)
10.2 Middle East & Africa Alzheimer’s Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Alzheimer’s Treatment Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Alzheimer’s Treatment Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Alzheimer’s Treatment Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Alzheimer’s Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Alzheimer’s Treatment Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Alzheimer’s Treatment Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Alzheimer’s Treatment Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Alzheimer’s Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Alzheimer’s Treatment Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Alzheimer’s Treatment Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eisai Co., Ltd.
11.1.1 Eisai Co., Ltd. Company Details
11.1.2 Eisai Co., Ltd. Business Overview
11.1.3 Eisai Co., Ltd. Alzheimer’s Treatment Drugs Introduction
11.1.4 Eisai Co., Ltd. Revenue in Alzheimer’s Treatment Drugs Business (2017-2022)
11.1.5 Eisai Co., Ltd. Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Alzheimer’s Treatment Drugs Introduction
11.2.4 Novartis AG Revenue in Alzheimer’s Treatment Drugs Business (2017-2022)
11.2.5 Novartis AG Recent Developments
11.3 Abbvie inc. (Allergan Plc)
11.3.1 Abbvie inc. (Allergan Plc) Company Details
11.3.2 Abbvie inc. (Allergan Plc) Business Overview
11.3.3 Abbvie inc. (Allergan Plc) Alzheimer’s Treatment Drugs Introduction
11.3.4 Abbvie inc. (Allergan Plc) Revenue in Alzheimer’s Treatment Drugs Business (2017-2022)
11.3.5 Abbvie inc. (Allergan Plc) Recent Developments
11.4 Adamas Pharmaceuticals, Inc.
11.4.1 Adamas Pharmaceuticals, Inc. Company Details
11.4.2 Adamas Pharmaceuticals, Inc. Business Overview
11.4.3 Adamas Pharmaceuticals, Inc. Alzheimer’s Treatment Drugs Introduction
11.4.4 Adamas Pharmaceuticals, Inc. Revenue in Alzheimer’s Treatment Drugs Business (2017-2022)
11.4.5 Adamas Pharmaceuticals, Inc. Recent Developments
11.5 H. Lundbeck A/S
11.5.1 H. Lundbeck A/S Company Details
11.5.2 H. Lundbeck A/S Business Overview
11.5.3 H. Lundbeck A/S Alzheimer’s Treatment Drugs Introduction
11.5.4 H. Lundbeck A/S Revenue in Alzheimer’s Treatment Drugs Business (2017-2022)
11.5.5 H. Lundbeck A/S Recent Developments
11.6 Biogen
11.6.1 Biogen Company Details
11.6.2 Biogen Business Overview
11.6.3 Biogen Alzheimer’s Treatment Drugs Introduction
11.6.4 Biogen Revenue in Alzheimer’s Treatment Drugs Business (2017-2022)
11.6.5 Biogen Recent Developments
11.7 AC Immune
11.7.1 AC Immune Company Details
11.7.2 AC Immune Business Overview
11.7.3 AC Immune Alzheimer’s Treatment Drugs Introduction
11.7.4 AC Immune Revenue in Alzheimer’s Treatment Drugs Business (2017-2022)
11.7.5 AC Immune Recent Developments
11.8 DAIICHI SANKYO COMPANY, LIMITED
11.8.1 DAIICHI SANKYO COMPANY, LIMITED Company Details
11.8.2 DAIICHI SANKYO COMPANY, LIMITED Business Overview
11.8.3 DAIICHI SANKYO COMPANY, LIMITED Alzheimer’s Treatment Drugs Introduction
11.8.4 DAIICHI SANKYO COMPANY, LIMITED Revenue in Alzheimer’s Treatment Drugs Business (2017-2022)
11.8.5 DAIICHI SANKYO COMPANY, LIMITED Recent Developments
11.9 Johnson & Johnson Services Inc
11.9.1 Johnson & Johnson Services Inc Company Details
11.9.2 Johnson & Johnson Services Inc Business Overview
11.9.3 Johnson & Johnson Services Inc Alzheimer’s Treatment Drugs Introduction
11.9.4 Johnson & Johnson Services Inc Revenue in Alzheimer’s Treatment Drugs Business (2017-2022)
11.9.5 Johnson & Johnson Services Inc Recent Developments
11.10 TauRx Pharmaceuticals Ltd
11.10.1 TauRx Pharmaceuticals Ltd Company Details
11.10.2 TauRx Pharmaceuticals Ltd Business Overview
11.10.3 TauRx Pharmaceuticals Ltd Alzheimer’s Treatment Drugs Introduction
11.10.4 TauRx Pharmaceuticals Ltd Revenue in Alzheimer’s Treatment Drugs Business (2017-2022)
11.10.5 TauRx Pharmaceuticals Ltd Recent Developments
11.11 F. Hoffmann La Roche Ltd.
11.11.1 F. Hoffmann La Roche Ltd. Company Details
11.11.2 F. Hoffmann La Roche Ltd. Business Overview
11.11.3 F. Hoffmann La Roche Ltd. Alzheimer’s Treatment Drugs Introduction
11.11.4 F. Hoffmann La Roche Ltd. Revenue in Alzheimer’s Treatment Drugs Business (2017-2022)
11.11.5 F. Hoffmann La Roche Ltd. Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Alzheimer's Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Cholinesterase Inhibitors
Table 3. Key Players of N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
Table 4. Key Players of Combination Drug
Table 5. Key Players of Others
Table 6. Global Alzheimer's Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Alzheimer's Treatment Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Alzheimer's Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Alzheimer's Treatment Drugs Market Share by Region (2017-2022)
Table 10. Global Alzheimer's Treatment Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Alzheimer's Treatment Drugs Market Share by Region (2023-2028)
Table 12. Alzheimer's Treatment Drugs Market Trends
Table 13. Alzheimer's Treatment Drugs Market Drivers
Table 14. Alzheimer's Treatment Drugs Market Challenges
Table 15. Alzheimer's Treatment Drugs Market Restraints
Table 16. Global Alzheimer's Treatment Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Alzheimer's Treatment Drugs Revenue Share by Players (2017-2022)
Table 18. Global Top Alzheimer's Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Treatment Drugs as of 2021)
Table 19. Ranking of Global Top Alzheimer's Treatment Drugs Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Alzheimer's Treatment Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Alzheimer's Treatment Drugs Product Solution and Service
Table 23. Date of Enter into Alzheimer's Treatment Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzheimer's Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Alzheimer's Treatment Drugs Revenue Market Share by Type (2017-2022)
Table 27. Global Alzheimer's Treatment Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Alzheimer's Treatment Drugs Revenue Market Share by Type (2023-2028)
Table 29. Global Alzheimer's Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Alzheimer's Treatment Drugs Revenue Share by Application (2017-2022)
Table 31. Global Alzheimer's Treatment Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Alzheimer's Treatment Drugs Revenue Share by Application (2023-2028)
Table 33. North America Alzheimer's Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Alzheimer's Treatment Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Alzheimer's Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Alzheimer's Treatment Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Alzheimer's Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Alzheimer's Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Alzheimer's Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Alzheimer's Treatment Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Alzheimer's Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Alzheimer's Treatment Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Alzheimer's Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Alzheimer's Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Alzheimer's Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Alzheimer's Treatment Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Alzheimer's Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Alzheimer's Treatment Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Alzheimer's Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Alzheimer's Treatment Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Alzheimer's Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Alzheimer's Treatment Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Alzheimer's Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Alzheimer's Treatment Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Alzheimer's Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Alzheimer's Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Alzheimer's Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Alzheimer's Treatment Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Alzheimer's Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Alzheimer's Treatment Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Alzheimer's Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Alzheimer's Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 63. Eisai Co., Ltd. Company Details
Table 64. Eisai Co., Ltd. Business Overview
Table 65. Eisai Co., Ltd. Alzheimer's Treatment Drugs Product
Table 66. Eisai Co., Ltd. Revenue in Alzheimer's Treatment Drugs Business (2017-2022) & (US$ Million)
Table 67. Eisai Co., Ltd. Recent Developments
Table 68. Novartis AG Company Details
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Alzheimer's Treatment Drugs Product
Table 71. Novartis AG Revenue in Alzheimer's Treatment Drugs Business (2017-2022) & (US$ Million)
Table 72. Novartis AG Recent Developments
Table 73. Abbvie inc. (Allergan Plc) Company Details
Table 74. Abbvie inc. (Allergan Plc) Business Overview
Table 75. Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Product
Table 76. Abbvie inc. (Allergan Plc) Revenue in Alzheimer's Treatment Drugs Business (2017-2022) & (US$ Million)
Table 77. Abbvie inc. (Allergan Plc) Recent Developments
Table 78. Adamas Pharmaceuticals, Inc. Company Details
Table 79. Adamas Pharmaceuticals, Inc. Business Overview
Table 80. Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Product
Table 81. Adamas Pharmaceuticals, Inc. Revenue in Alzheimer's Treatment Drugs Business (2017-2022) & (US$ Million)
Table 82. Adamas Pharmaceuticals, Inc. Recent Developments
Table 83. H. Lundbeck A/S Company Details
Table 84. H. Lundbeck A/S Business Overview
Table 85. H. Lundbeck A/S Alzheimer's Treatment Drugs Product
Table 86. H. Lundbeck A/S Revenue in Alzheimer's Treatment Drugs Business (2017-2022) & (US$ Million)
Table 87. H. Lundbeck A/S Recent Developments
Table 88. Biogen Company Details
Table 89. Biogen Business Overview
Table 90. Biogen Alzheimer's Treatment Drugs Product
Table 91. Biogen Revenue in Alzheimer's Treatment Drugs Business (2017-2022) & (US$ Million)
Table 92. Biogen Recent Developments
Table 93. AC Immune Company Details
Table 94. AC Immune Business Overview
Table 95. AC Immune Alzheimer's Treatment Drugs Product
Table 96. AC Immune Revenue in Alzheimer's Treatment Drugs Business (2017-2022) & (US$ Million)
Table 97. AC Immune Recent Developments
Table 98. DAIICHI SANKYO COMPANY, LIMITED Company Details
Table 99. DAIICHI SANKYO COMPANY, LIMITED Business Overview
Table 100. DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Product
Table 101. DAIICHI SANKYO COMPANY, LIMITED Revenue in Alzheimer's Treatment Drugs Business (2017-2022) & (US$ Million)
Table 102. DAIICHI SANKYO COMPANY, LIMITED Recent Developments
Table 103. Johnson & Johnson Services Inc Company Details
Table 104. Johnson & Johnson Services Inc Business Overview
Table 105. Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Product
Table 106. Johnson & Johnson Services Inc Revenue in Alzheimer's Treatment Drugs Business (2017-2022) & (US$ Million)
Table 107. Johnson & Johnson Services Inc Recent Developments
Table 108. TauRx Pharmaceuticals Ltd Company Details
Table 109. TauRx Pharmaceuticals Ltd Business Overview
Table 110. TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Product
Table 111. TauRx Pharmaceuticals Ltd Revenue in Alzheimer's Treatment Drugs Business (2017-2022) & (US$ Million)
Table 112. TauRx Pharmaceuticals Ltd Recent Developments
Table 113. F. Hoffmann La Roche Ltd. Company Details
Table 114. F. Hoffmann La Roche Ltd. Business Overview
Table 115. F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Product
Table 116. F. Hoffmann La Roche Ltd. Revenue in Alzheimer's Treatment Drugs Business (2017-2022) & (US$ Million)
Table 117. F. Hoffmann La Roche Ltd. Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer's Treatment Drugs Market Share by Type: 2021 VS 2028
Figure 2. Cholinesterase Inhibitors Features
Figure 3. N-Methyl-D-Aspartate (NMDA) Receptor Antagonist Features
Figure 4. Combination Drug Features
Figure 5. Others Features
Figure 6. Global Alzheimer's Treatment Drugs Market Share by Application: 2021 VS 2028
Figure 7. Online Sales Case Studies
Figure 8. Offline Sales Case Studies
Figure 9. Alzheimer's Treatment Drugs Report Years Considered
Figure 10. Global Alzheimer's Treatment Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Alzheimer's Treatment Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Alzheimer's Treatment Drugs Market Share by Region: 2021 VS 2028
Figure 13. Global Alzheimer's Treatment Drugs Market Share by Players in 2021
Figure 14. Global Top Alzheimer's Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Treatment Drugs as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Alzheimer's Treatment Drugs Revenue in 2021
Figure 16. North America Alzheimer's Treatment Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Alzheimer's Treatment Drugs Market Size Market Share by Type (2017-2028)
Figure 18. North America Alzheimer's Treatment Drugs Market Size Market Share by Application (2017-2028)
Figure 19. North America Alzheimer's Treatment Drugs Market Size Share by Country (2017-2028)
Figure 20. United States Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Alzheimer's Treatment Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Alzheimer's Treatment Drugs Market Size Market Share by Type (2017-2028)
Figure 24. Europe Alzheimer's Treatment Drugs Market Size Market Share by Application (2017-2028)
Figure 25. Europe Alzheimer's Treatment Drugs Market Size Share by Country (2017-2028)
Figure 26. Germany Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Alzheimer's Treatment Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Alzheimer's Treatment Drugs Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Alzheimer's Treatment Drugs Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Alzheimer's Treatment Drugs Market Size Share by Region (2017-2028)
Figure 36. China Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Alzheimer's Treatment Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Alzheimer's Treatment Drugs Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Alzheimer's Treatment Drugs Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Alzheimer's Treatment Drugs Market Size Share by Country (2017-2028)
Figure 46. Mexico Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Alzheimer's Treatment Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Alzheimer's Treatment Drugs Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Alzheimer's Treatment Drugs Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Alzheimer's Treatment Drugs Market Size Share by Country (2017-2028)
Figure 52. Turkey Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Alzheimer's Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Eisai Co., Ltd. Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2017-2022)
Figure 56. Novartis AG Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2017-2022)
Figure 57. Abbvie inc. (Allergan Plc) Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2017-2022)
Figure 58. Adamas Pharmaceuticals, Inc. Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2017-2022)
Figure 59. H. Lundbeck A/S Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2017-2022)
Figure 60. Biogen Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2017-2022)
Figure 61. AC Immune Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2017-2022)
Figure 62. DAIICHI SANKYO COMPANY, LIMITED Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2017-2022)
Figure 63. Johnson & Johnson Services Inc Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2017-2022)
Figure 64. TauRx Pharmaceuticals Ltd Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2017-2022)
Figure 65. F. Hoffmann La Roche Ltd. Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed